Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
30,07 USD | +2,59% | +2,28% | +3,90% |
Attività
Numero di dipendenti: 652
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Treatment of Central Nervous System Diseases
100,0
%
| 667 | 100,0 % | 608 | 100,0 % | -8,95% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 667 | 100,0 % | 608 | 100,0 % | -8,95% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 30/03/05 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 23/08/21 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/05 |
Jonathan Rubin
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/02/20 |
Chief Tech/Sci/R&D Officer | 66 | 30/03/05 | |
Compliance Officer | 61 | 01/01/12 | |
Taylor Raiford
SAM | Sales & Marketing | - | 01/01/15 |
Todd Horich
SAM | Sales & Marketing | - | 31/05/18 |
Corporate Officer/Principal | - | 01/07/15 | |
Tami Martin
LAW | General Counsel | 68 | 01/01/08 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 23/03/15 |
Charles Newhall
CHM | Chairman | 79 | 30/03/05 |
John Siebert
BRD | Director/Board Member | 84 | 01/01/11 |
Frederick Hudson
BRD | Director/Board Member | 78 | 16/11/10 |
Carrolee Barlow
BRD | Director/Board Member | 60 | 27/06/18 |
Jack Khattar
FOU | Founder | 62 | 30/03/05 |
Bethany Sensenig
BRD | Director/Board Member | 48 | 21/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 54 734 956 | 51 934 710 ( 94,88 %) | 0 | 94,88 % |
Coordinate società
Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
20850, Rockville
+301 838 2500
http://www.supernus.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+3,90% | 1,65 Mrd | |
+5,31% | 70,44 Mrd | |
+10,97% | 8,94 Mrd | |
-16,83% | 4,75 Mrd | |
+43,48% | 4,5 Mrd | |
+3,20% | 3,85 Mrd | |
+18,82% | 2,38 Mrd | |
-21,36% | 2,34 Mrd | |
-29,67% | 2,2 Mrd | |
+8,38% | 1,96 Mrd |
- Borsa valori
- Azioni
- Azione SUPN
- Società Supernus Pharmaceuticals, Inc.